Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001236368-13-000002
Filing Date
2013-12-06
Accepted
2013-12-06 15:28:33
Documents
1
Period of Report
2013-12-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3773
  Complete submission text file 0001236368-13-000002.txt   5101
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O TRANSKARYOTIC THERAPIES INC 700 MAIN STREET CAMBRIDGE MA 02139
Business Address
GILBERT WALTER PHD (Reporting) CIK: 0001236368 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 131262900